BPC-157 and TB-500 are the two most frequently compared — and combined — tissue-response research peptides, despite acting through different mechanisms.
Different mechanisms
BPC-157 is studied in angiogenesis-related and cytoprotection signaling. TB-500, a Thymosin Beta-4 fragment, is studied for actin regulation and cell migration. They approach tissue-response from complementary angles.
Why they are studied together
Because the mechanisms differ, researchers pair them in combination protocols — the basis of the BPC-157 + TB-500 research stack. See peptide blends and research stacks.
Product pages: BPC-157 · BPC-157 + TB-500 stack.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.